Funding from Ontario Institute for Cancer Research to help move research from experiment to impact
First round of Innovation to Implementation Supplement (I2IS) grants awarded to five promising research projects taking unique approaches to addressing cancer.
Excerpt from the Press Release:
August 11, 2022, TORONTO – Five Ontario-based research projects will take the next step toward advancing cancer care in the province thanks to funding from the Ontario Institute for Cancer Research (OICR).
OICR is announcing the first round of recipients of its new Innovation to Implementation Supplement (I2IS), which aims to help discoveries in cancer overcome barriers to health system implementation. All five projects advance research programs that were previously funded by OICR within the past five years. The supplemental funding announced today completes the continuum for these projects, helping them build on their previous success and translate what they have already learned into real-world impact.
“With Ontario’s population aging and the number of cancer diagnoses on the rise, translational cancer research that makes a difference in people’s lives is more important than ever,” said OICR President and Scientific Director Dr. Laszlo Radvanyi. “OICR is proud to have supported these innovative projects over the past few years and we hope this new funding will give them an extra push to take the next step now and shape cancer care and policy in Ontario.”
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?